The reactions between [Pd(C(2),N-dmba)(micro-X)](2) (dmba=N,N-dimethylbenzylamine; X=Cl, Br) and thiourea (tu) in the 1:2 molar ratio at room temperature resulted in the mononuclear compounds [Pd(C(2),N-dmba)(Cl)(tu)] (1) and [Pd(C(2),N-dmba)(Br)(tu)] (2), which were characterized by elemental analyses and infrared (IR), (1)H- and (13)C{(1)H} NMR spectroscopies. The crystal and molecular structures of 2 were determined by single-crystal X-ray diffraction. In vitro cytotoxicity assays of the compounds 1, 2, tu, dmba and cisplatin were carried out using two murine tumor cell lines, namely mammary adenocarcinoma (LM3) and lung adenocarcinoma (LP07). The compounds 1, 2, tu and dmba were also tested against Mycobacterium tuberculosis and their MIC values were determined.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejmech.2009.06.032 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Targeting Yes-Associated Protein (YAP) in Breast Cancer: In Silico Molecular Dynamics, Luminescence-Based In Vitro, and In Vivo Validation of Rauvolfia tetraphylla-Derived Inhibitors.
Luminescence
December 2024
Biological and Environmental Sensing Research Unit, King Abdullah Institute for Nanotechnology, King Saud University, Riyadh, Saudi Arabia.
The study aims to elucidate the pharmacological mechanism of Rauvolfia tetraphylla against breast cancer through a comprehensive, multi-faceted approach. This includes molecular docking, molecular dynamics, and experimental validation. Initial screening via ADME analysis and network pharmacology identified key compounds and potential targets.
View Article and Find Full Text PDFExposure to brominated flame retardants and through lactation delays the development of DMBA-induced mammary cancer: potential effects on subtypes?
Front Endocrinol (Lausanne)
November 2024
INRS-Centre Armand-Frappier Santé Biotechnologie, Laval, QC, Canada.
Introduction: Brominated flame retardants (BFRs) are chemical compounds used to reduce the flammability of various products; some BFRs exhibit endocrine-disrupting properties and can leach into the environment leading to human and wildlife exposure. The mammary gland has specific vulnerability windows during which it is more sensitive to the effects of endocrine disrupting compounds (EDCs), such as the life, puberty and pregnancy. Our previous studies revealed precocious mammary gland development, disruptions in junctional proteins, and altered proliferation-apoptosis balance during puberty in rats exposed to BFRs and through lactation.
View Article and Find Full Text PDFBlack soybean extract inhibits rat mammary carcinogenesis through BRCA1 and TNF-α expression: and study.
Open Vet J
October 2024
Department of Veterinary Clinical Studies, Faculty of Veterinary Medicine, Universiti Malaysia Kelantan, Kota Bharu, Kelantan, 16100, Malaysia.
Article Synopsis
- - Mammary gland carcinoma is a serious cancer caused by the carcinogen DMBA, which damages DNA, while flavonoids in black soybean possess anti-cancer properties.
- - A study tested the effects of black soybean extract on cancer in rats, using different dosages and measuring their impact on cancer-related proteins BRCA1 and TNF-α.
- - Results showed that black soybean extract is non-toxic and effectively inhibits cancer progression, with the best dosage being 200 mg/kg body weight, likely due to components like catechin and genistein.
A novel quinazoline derivative exhibits potent anticancer cytotoxicity via apoptosis and inhibition of angiogenesis in DMBA-induced mammary gland carcinoma.
J Biochem Mol Toxicol
November 2024
Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University (A Central University), Lucknow, India.
Mammary gland carcinoma is one of the most prevalent and deadly diseases among women globally. It is a type of solid malignant tumor. In this malignant tumor, the microenvironment becomes hypoxic in rapidly proliferating cancer cells.
View Article and Find Full Text PDFPLGA-Loaded Nedaplatin (PLGA-NDP) Inhibits 7,12-Dimethylbenz[a]anthracene (DMBA) Induced Oral Carcinogenesis via Modulating Notch Signaling Pathway and Induces Apoptosis in Experimental Hamster Model.
Cell Biochem Funct
September 2024
Department of Biochemistry and Biotechnology, Annamalai University, Chidambaram, Tamil Nadu, India.
Article Synopsis
- The study assesses the effectiveness of PLGA-loaded Nedaplatin (PLGA-NDP) in treating oral cancer induced by DMBA in a hamster model, where DMBA exposure led to the development of oral squamous cell carcinoma (OSCC).
- PLGA-NDP was administered both before and after carcinogen exposure, showing promising results in reducing tumor formation and altering key molecular proteins associated with cancer progression.
- Findings revealed that PLGA-NDP inhibits Notch signaling, which is linked to apoptosis, suggesting that targeting this pathway could provide a new strategy for treating OSCC.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!